Industry Outlook

The preterm birth and PROM testing market is set to growth at a compounded annual growth rate (CAGR) of 2.1% during the forecast period from 2023 to 2030. As per the research findings of World Health Organization (WHO), annually 15 million babies are born before the completion of 37 weeks of normal pregnancy and as a result approximately 1 million children die every year due to complications associated with preterm births.

Excellent diagnostic accuracy and sensitivity will increase the popularity of biomarkers as PROM testing kits

Physicians investigate preliminary symptoms such as vaginal bleeding, vaginal discharge, pelvic pressure etc., to confirm preterm birth complications. Pelvic examination is the first line of diagnostic approach which is performed several times over a period of time to study the contraction and changes of cervix. If the cervix begins to soften, dilate and become thin before 37 weeks of pregnancy the patient is diagnosed with preterm labor. Biomarkers such as Alpha-fetoprotein test (AFT), insulin like growth factor binding protein-1 (IGFBP-1), placental alpha macroglobulin-1 (PAMG-1) etc., are gaining tremendous attention in the last decade. Excellent diagnostic accuracy and sensitivity increases the popularity of biomarkers as PROM testing kits.

"Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region"

In the present scenario North America is leading the regional segment for preterm birth and PROM testing market with a share of 36%. Annually 3.9 million babies are born in North America of which 12.0% are born prematurely. Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region. Existence of major players such as Abbott Laboratories, Inc., CooperSurgical, Inc., Qiagen, Inc., Hologic, Inc. etc. further propel the market growth in North America region. Europe is the second largest market with a share of 28% on account of supportive regulatory environment provided by the European Medical Agency (EMA) for PROM testing kits and establishment of well-developed healthcare infrastructure. Asia Pacific currently holds 15% market share and will be showcasing rapid growth in the near future owing to increasing complication related to pregnancy and proactive government initiatives to provide optimum maternal care.

Biopharmaceutical companies specializing in manufacturing preterm birth and PROM testing kits are Abbott Laboratories, Inc., Biosynex, Clinical Innovations, LLC, CooperSurgical, Inc., Hologic, Inc., IQ Products, Medixbiochemica, NX Prenatal, Inc., Qiagen N.V. and Sera Prognostics, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Preterm Birth And PROM Testing market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Preterm Birth And PROM Testing market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Preterm Birth And PROM Testing market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Preterm Birth And PROM Testing market?
• Which is the largest regional market for Preterm Birth And PROM Testing market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Preterm Birth And PROM Testing market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Preterm Birth And PROM Testing market worldwide?